nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abbreviated cyclosporine pharmacokinetic profiling in clinical renal transplantation: from principles to practice
|
Vathsala, A |
|
2001 |
33 |
7-8 |
p. 3137-3139 3 p. |
artikel |
2 |
Absence of acute rejection using basiliximab with triple immunosuppression in cadaveric kidney recipients in first three months
|
Kandus, A. |
|
2001 |
33 |
7-8 |
p. 3207-3208 2 p. |
artikel |
3 |
Achieving clinical transplant tolerance: what are the hurdles?
|
Salamam, A.D. |
|
2001 |
33 |
7-8 |
p. 3038-3040 3 p. |
artikel |
4 |
Advances in segmental liver transplantation: can we solve the donor shortage?
|
Guarrera, J.V. |
|
2001 |
33 |
7-8 |
p. 3451-3455 5 p. |
artikel |
5 |
Aerobic ischemia by venous systemic O2 Persufflation (VSOP) during cold storage of predamaged livers: molecular impact and physiologic benefit
|
Akbar, S. |
|
2001 |
33 |
7-8 |
p. 3716-3717 2 p. |
artikel |
6 |
Alloantigen recognition pathways and transplant tolerance
|
Pettigrew, G.J. |
|
2001 |
33 |
7-8 |
p. 3811-3813 3 p. |
artikel |
7 |
Allogeneic stem cells, clinical transplantation, and the origins of regenerative medicine
|
Strom, T.B. |
|
2001 |
33 |
7-8 |
p. 3044-3049 6 p. |
artikel |
8 |
Analysis of liver allograft rejection related genes using cDNA-microarrays in liver allograft specimen
|
Tannapfel, A. |
|
2001 |
33 |
7-8 |
p. 3283-3284 2 p. |
artikel |
9 |
Analysis of neurologic complications within the first 30 days after orthotopic liver transplantation
|
Boin, I.F.S.F |
|
2001 |
33 |
7-8 |
p. 3695-3696 2 p. |
artikel |
10 |
Ancient proteins and futuristic surgery: the role of complement in discordant xenograft rejection
|
Winkler, M. |
|
2001 |
33 |
7-8 |
p. 3862-3864 3 p. |
artikel |
11 |
Angiotensin receptor antagonism in patients after renal transplantation: effects on glomerular function and tgf-β1 plasma levels
|
Hetzel, G.R. |
|
2001 |
33 |
7-8 |
p. 3370-3372 3 p. |
artikel |
12 |
An impaired cardiodynamic phase contributes to the abnormal vo2 kinetics at exercise onset in both congestive heart failure and heart transplant patients but results from differing mechanisms
|
M’Bouh, S |
|
2001 |
33 |
7-8 |
p. 3543-3545 3 p. |
artikel |
13 |
An oral formulation for intracellular adhesion molecules-1 antisense oligonucleotides
|
Stepkowski, S.M. |
|
2001 |
33 |
7-8 |
p. 3271- 1 p. |
artikel |
14 |
A novel model of pig-to-monkey kidney xenotransplantation
|
Wang, X.M. |
|
2001 |
33 |
7-8 |
p. 3859- 1 p. |
artikel |
15 |
Anti-CD25 prophylaxis allows steroid free kidney transplantation
|
Weimar, W. |
|
2001 |
33 |
7-8 |
p. 3176-3177 2 p. |
artikel |
16 |
A pilot study comparing basiliximab and anti-thymocyte globulin as induction therapy in sensitized renal allograft recipients
|
Mariat, C. |
|
2001 |
33 |
7-8 |
p. 3192-3193 2 p. |
artikel |
17 |
A pilot study of steroid withdrawal from kidney transplant recipients on sirolimus-cyclosporine a combination therapy
|
Mahalati, K. |
|
2001 |
33 |
7-8 |
p. 3232-3233 2 p. |
artikel |
18 |
A single center experience with basiliximab induction therapy in renal transplantation
|
Henry, M.L. |
|
2001 |
33 |
7-8 |
p. 3178-3179 2 p. |
artikel |
19 |
A single-centre experience with cyclosporine microemulsion versus tacrolimus in 100 randomized liver transplant recipients: midterm efficacy and safety
|
Loinaz, C. |
|
2001 |
33 |
7-8 |
p. 3439-3441 3 p. |
artikel |
20 |
A study of cobra venom factor in ex vivo pig liver perfusion model
|
Shen, S.Q. |
|
2001 |
33 |
7-8 |
p. 3860-3861 2 p. |
artikel |
21 |
A study of human DAF, cd59, MCP transgene in xenotransplantation
|
Chen, S. |
|
2001 |
33 |
7-8 |
p. 3851-3852 2 p. |
artikel |
22 |
2001: a transplant odyssey
|
Kahan, B.D. |
|
2001 |
33 |
7-8 |
p. 3025-3026 2 p. |
artikel |
23 |
2001, a transplant odyssey: Epilogue
|
Kahan, B.D. |
|
2001 |
33 |
7-8 |
p. 3875- 1 p. |
artikel |
24 |
2001: a transplant odyssey opening speech
|
Rosenberg, T. |
|
2001 |
33 |
7-8 |
p. 3030-3031 2 p. |
artikel |
25 |
Attitudes of 15-year-old children toward cadaveric organ donation and transplantation
|
Orlic, P |
|
2001 |
33 |
7-8 |
p. 3615-3616 2 p. |
artikel |
26 |
Author index
|
|
|
2001 |
33 |
7-8 |
p. 3877-3884 8 p. |
artikel |
27 |
Autotransplantation of heart for repair of left ventricular rupture after mitral valve replacement
|
Wei, J. |
|
2001 |
33 |
7-8 |
p. 3553-3554 2 p. |
artikel |
28 |
Basiliximab can be administered safely and effectively in a single dose on day 1 postrenal transplantation in patients receiving triple therapy with azathioprine
|
Matl, I |
|
2001 |
33 |
7-8 |
p. 3205-3206 2 p. |
artikel |
29 |
Basiliximab versus ATG/ALG induction in pediatric renal transplants: comparison of herpes virus profile and rejection rates
|
Acott, P.D |
|
2001 |
33 |
7-8 |
p. 3180-3183 4 p. |
artikel |
30 |
Benefits of cyclosporine microemulsion (Neoral) C2 monitoring are sustained at 1 year in de novo liver transplant recipients
|
Lake, J.R. |
|
2001 |
33 |
7-8 |
p. 3092-3093 2 p. |
artikel |
31 |
Biologic behavior of carcinoid tumors in solid organ transplant recipients: the Israel Penn international transplant tumor registry experience
|
Woodle, E.S. |
|
2001 |
33 |
7-8 |
p. 3656-3657 2 p. |
artikel |
32 |
Biopsy-proven resolution of steroid-resistant acute rejection with basiliximab therapy in a renal allograft recipient
|
Goh, H.K. |
|
2001 |
33 |
7-8 |
p. 3213-3214 2 p. |
artikel |
33 |
Bone mineral density in kidney transplant recipients
|
Kovac̆, D. |
|
2001 |
33 |
7-8 |
p. 3668-3669 2 p. |
artikel |
34 |
Bronchiolitis obliterans syndrome in transplanted patients: findings on spirometrically guided high-resolution computed tomography
|
Ewert, R. |
|
2001 |
33 |
7-8 |
p. 3576-3577 2 p. |
artikel |
35 |
Can three-times-a-aay cyclosporine neoral avoid cylosporine toxicity in renal transplant recipients? a pharmacokinetic study
|
Swart, N. |
|
2001 |
33 |
7-8 |
p. 3140-3141 2 p. |
artikel |
36 |
Carbon dioxide subtraction angiography for management of kidney transplant vascular complications
|
Nicolini, A. |
|
2001 |
33 |
7-8 |
p. 3388-3389 2 p. |
artikel |
37 |
Cardiovascular and metabolic complications after liver transplantation: neoral- versus tacrolimus-based immunosuppression
|
Risaliti, A. |
|
2001 |
33 |
7-8 |
p. 3684-3685 2 p. |
artikel |
38 |
Cardiovascular risk factors in recipients of successful kidney-pancreas transplantation
|
Coppelli, A |
|
2001 |
33 |
7-8 |
p. 3681- 1 p. |
artikel |
39 |
Case-based reasoning algorithm for kidney transplant monitoring
|
Fritsche, L |
|
2001 |
33 |
7-8 |
p. 3331-3333 3 p. |
artikel |
40 |
C2 blood levels in heart-transplanted patients immunosuppressed on a trough level-;based regimen
|
Fiocchi, R. |
|
2001 |
33 |
7-8 |
p. 3115-3116 2 p. |
artikel |
41 |
CD4 and CD8 cytokine-producing T cells are transiently reduced following cyclosporine intake: maximal inhibition occurs at 2 hours coincidental with drug Cmax
|
Mora, J.R. |
|
2001 |
33 |
7-8 |
p. 3310-3312 3 p. |
artikel |
42 |
Chemokines: reliable markers for diagnosis of rejection and inflammation following orthotopic liver transplantation
|
Moench, Ch |
|
2001 |
33 |
7-8 |
p. 3293-3294 2 p. |
artikel |
43 |
Chronic allograft nephropathy: what can the biopsy tell us?
|
Furness, P.N. |
|
2001 |
33 |
7-8 |
p. 3357-3358 2 p. |
artikel |
44 |
Chronic rejection: a significant predictor of poor outcome for recurrence IgA nephropathy
|
Sumethkul, V. |
|
2001 |
33 |
7-8 |
p. 3375-3376 2 p. |
artikel |
45 |
Circulating adrenomedullin is increased after renal transplantation
|
Geny, B. |
|
2001 |
33 |
7-8 |
p. 3396-3397 2 p. |
artikel |
46 |
Clinical islet transplant—state of the art
|
Shapiro, A.M.J. |
|
2001 |
33 |
7-8 |
p. 3502-3503 2 p. |
artikel |
47 |
Clinical markers and modifiable cardiovascular risk factors after kidney transplantation
|
Arias, M |
|
2001 |
33 |
7-8 |
p. 3677-3678 2 p. |
artikel |
48 |
Clinical validation of the banff 97 classification for the diagnosis of rejection in kidney transplant
|
Palomar, R. |
|
2001 |
33 |
7-8 |
p. 3309- 1 p. |
artikel |
49 |
Comparative study of population pharmacokinetics upon switching of cyclosporine formulation from sandimmune to neoral in stable renal transplant patients
|
Yoshida, K |
|
2001 |
33 |
7-8 |
p. 3146-3147 2 p. |
artikel |
50 |
Comparison of the efficacy in prevention of hepatitis B virus recurrence after liver transplantation between HBIG and lamivudine
|
Lee, K.W |
|
2001 |
33 |
7-8 |
p. 3643-3644 2 p. |
artikel |
51 |
Comparison of trough level and C2 cyclosporine blood concentration monitoring in outpatient kidney transplant recipients
|
Braun, F. |
|
2001 |
33 |
7-8 |
p. 3108-3109 2 p. |
artikel |
52 |
Construction of an optimal facility for clinical pancreatic islet isolation
|
Rastellini, C. |
|
2001 |
33 |
7-8 |
p. 3524- 1 p. |
artikel |
53 |
Continuous subcutaneous insulin infusion in a patient with partial endocrine pancreatic graft function
|
Giannarelli, R |
|
2001 |
33 |
7-8 |
p. 3500-3501 2 p. |
artikel |
54 |
Contractility, myocardial blood flow, and metabolic activity 24 hours after orthotopic heart transplantation from non-heart-beating donors: in vivo investigations in the Pig Model
|
Martin, J |
|
2001 |
33 |
7-8 |
p. 3739-3740 2 p. |
artikel |
55 |
Control of risk factors for cardiovascular disease in long-term renal transplant recipients
|
First, M.R. |
|
2001 |
33 |
7-8 |
p. 3674-3675 2 p. |
artikel |
56 |
Conversion from cyclosporine to tacrolimus for refractory acute rejection in pediatric kidney transplant recipients: a single-center experience
|
Ferraresso, M. |
|
2001 |
33 |
7-8 |
p. 3590-3591 2 p. |
artikel |
57 |
Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients
|
Blume, C. |
|
2001 |
33 |
7-8 |
p. 3161-3163 3 p. |
artikel |
58 |
Conversion from tacrolimus to neoral in liver and kidney transplant recipients
|
Ott, R |
|
2001 |
33 |
7-8 |
p. 3166-3168 3 p. |
artikel |
59 |
Conversion to neoral for tacrolimus-related adverse effects in liver transplant recipients and improvement in quality of life
|
Tolba, R.H. |
|
2001 |
33 |
7-8 |
p. 3446-3447 2 p. |
artikel |
60 |
Conversion to rapamycin in renal allograft recipients with biopsy-proven calcineurin inhibitor-induced nephrotoxicity
|
Diekmann, F. |
|
2001 |
33 |
7-8 |
p. 3234-3235 2 p. |
artikel |
61 |
Coronary angiography in heart donors: a necessity or a luxury?
|
Grauhan, O. |
|
2001 |
33 |
7-8 |
p. 3805- 1 p. |
artikel |
62 |
Correlation of captopril magnetic resonance renogram and perfusion changes with severity of renal allograft artery stenosis
|
Sharma, R.K. |
|
2001 |
33 |
7-8 |
p. 3381-3382 2 p. |
artikel |
63 |
Corticosteroids enhance hepatic injury following ischemia-reperfusion
|
Sileri, P. |
|
2001 |
33 |
7-8 |
p. 3712- 1 p. |
artikel |
64 |
Cost-effectiveness of early living related segmental bowel transplantation as therapy for trauma-induced irreversible intestinal failure
|
Cicalese, L. |
|
2001 |
33 |
7-8 |
p. 3581-3582 2 p. |
artikel |
65 |
Cost-minimization study comparing simulect versus thymoglobulin in renal transplant induction
|
Lilliu, H |
|
2001 |
33 |
7-8 |
p. 3197-3198 2 p. |
artikel |
66 |
Covariates influencing outcomes of old cadaveric donor kidney transplants
|
Bertoni, E |
|
2001 |
33 |
7-8 |
p. 3798-3800 3 p. |
artikel |
67 |
Creatinine clearance in recipients of kidneys from non-heart-beating donors
|
Gok, M.A |
|
2001 |
33 |
7-8 |
p. 3777-3778 2 p. |
artikel |
68 |
CSA/MMF/steroids versus CSA/AZA/steroids with and without basiliximab in cadaveric kidney transplantation
|
Boggi, U |
|
2001 |
33 |
7-8 |
p. 3199-3200 2 p. |
artikel |
69 |
C2 single-point sampling to evaluate cyclosporine exposure in long-term renal transplant recipients
|
Citterio, F |
|
2001 |
33 |
7-8 |
p. 3133-3136 4 p. |
artikel |
70 |
Current status of heart and lung transplantation
|
Barr, M.L. |
|
2001 |
33 |
7-8 |
p. 3564-3565 2 p. |
artikel |
71 |
Cyclosporine A: peak or trough level monitoring in renal transplant recipients?
|
Wacke, R. |
|
2001 |
33 |
7-8 |
p. 3122-3123 2 p. |
artikel |
72 |
Cyclosporine-associated encephalopathy: a case report and literature review
|
Chang, S.H. |
|
2001 |
33 |
7-8 |
p. 3700-3701 2 p. |
artikel |
73 |
Cyclosporine dose fractioning might affect renal function in stable heart transplanted patients
|
Baraldo, M. |
|
2001 |
33 |
7-8 |
p. 3151-3153 3 p. |
artikel |
74 |
Cyclosporine level: which single-point estimation of drug level is the best?
|
Sharma, R. |
|
2001 |
33 |
7-8 |
p. 3124-3125 2 p. |
artikel |
75 |
Cyclosporine microemulsion and tacrolimus are associated with decreased chronic allograft failure and improved long-term graft survival as compared to sandimmune
|
Meier-Kriesche, H.U. |
|
2001 |
33 |
7-8 |
p. 3422-3423 2 p. |
artikel |
76 |
Cyclosporine neoral profiling in japanese renal transplant recipients
|
Aikawa, A |
|
2001 |
33 |
7-8 |
p. 3142-3145 4 p. |
artikel |
77 |
Cyclosporine peak concentration in relation to the four-hour absorption phase in pediatric renal graft recipients
|
Wigger, M. |
|
2001 |
33 |
7-8 |
p. 3126-3127 2 p. |
artikel |
78 |
Cyclosporine-triggered hemolytic-uremic syndrome in kidney graft recipients: a series of 12 cases
|
Bren, A.F. |
|
2001 |
33 |
7-8 |
p. 3691-3692 2 p. |
artikel |
79 |
Cytokine release from liver grafts during cold ischemia
|
Schenk, M. |
|
2001 |
33 |
7-8 |
p. 3722-3723 2 p. |
artikel |
80 |
Cytomegalovirus infection after liver transplantation using different prophylaxes
|
Kornberg, A. |
|
2001 |
33 |
7-8 |
p. 3624-3625 2 p. |
artikel |
81 |
Death after graft loss: a novel endpoint for renal tranplantation
|
Meier-Kriesche, H.-U |
|
2001 |
33 |
7-8 |
p. 3405-3406 2 p. |
artikel |
82 |
Death of alloreactive T cells sets the stage for immunoregulation to act
|
Li, X.C. |
|
2001 |
33 |
7-8 |
p. 3041-3043 3 p. |
artikel |
83 |
Decreasing side effects of neoral through three-times-a-day protocol in chinese renal transplant patients
|
Chen, Z.S |
|
2001 |
33 |
7-8 |
p. 3156-3157 2 p. |
artikel |
84 |
Dendritic cells, generated in vitro, are immunocompetent and very useful in the induction of specific cytotoxic T lymphocyte activity
|
Hasel, T |
|
2001 |
33 |
7-8 |
p. 3814-3815 2 p. |
artikel |
85 |
De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine a sirolimus combination
|
Langer, R.M. |
|
2001 |
33 |
7-8 |
p. 3236-3237 2 p. |
artikel |
86 |
De novo noncutaneous malignancies in heart transplantation: a single-centre 15-year experience and risk factor analysis
|
Caforio, A.L.P. |
|
2001 |
33 |
7-8 |
p. 3658-3659 2 p. |
artikel |
87 |
Depressive symptoms and kidney transplant outcome
|
Rocha, G. |
|
2001 |
33 |
7-8 |
p. 3424- 1 p. |
artikel |
88 |
Detection of cardiac myosin-specific autoimmunity in a model of chronic heart allograft rejection
|
Rolls, H.K. |
|
2001 |
33 |
7-8 |
p. 3821-3822 2 p. |
artikel |
89 |
Development of transplantation in Turkey
|
Haberal, M. |
|
2001 |
33 |
7-8 |
p. 3027-3029 3 p. |
artikel |
90 |
Differential activity of plasma and endoplasmic reticulum membrane Ca2+-ATPases in porcine hepatocytes
|
Belous, A.E. |
|
2001 |
33 |
7-8 |
p. 3720-3721 2 p. |
artikel |
91 |
Differentiation of CMV-specific CD8POS T lymphocytes in primary CMV infection after renal transplantation
|
ten Berge, I.J.M. |
|
2001 |
33 |
7-8 |
p. 3630- 1 p. |
artikel |
92 |
Disorders of coagulation unrelated to xenograft rejection following pig-to-cynomolgus kidney transplantation
|
Loss, M. |
|
2001 |
33 |
7-8 |
p. 3867-3868 2 p. |
artikel |
93 |
Does previous thoracic surgery increase perioperative risk in lung transplantation?
|
Hirt, S.W. |
|
2001 |
33 |
7-8 |
p. 3572-3573 2 p. |
artikel |
94 |
Does taking part in multiple clinical studies with new immunosuppressive agents affect the outcome of renal transplantation?
|
Rigotti, P |
|
2001 |
33 |
7-8 |
p. 3427-3428 2 p. |
artikel |
95 |
Does the distribution of circulating CD4+CD28+, CD4+CD25+ T lymphocytes indicate subclinical rejection in patients in the early postoperative state of renal transplantation?
|
Satoh, S |
|
2001 |
33 |
7-8 |
p. 3301-3302 2 p. |
artikel |
96 |
Donor and recipient risk factors and choice of immunosuppression determine long-term outcome in renal transplantation
|
Mathew, T.H. |
|
2001 |
33 |
7-8 |
p. 3400-3402 3 p. |
artikel |
97 |
Duplex doppler follow-up of renal transplant artery stenosis in children
|
Ponikvar, J.Buturović |
|
2001 |
33 |
7-8 |
p. 3599-3601 3 p. |
artikel |
98 |
Effect of antisense oligonucleotides for tissue factor on hepatic ischemia-reperfusion injury in the rat
|
Nakamura, K. |
|
2001 |
33 |
7-8 |
p. 3707-3708 2 p. |
artikel |
99 |
Effect of apolipoprotein E and C-III polymorphisms on lipid profile and cardiovascular risk in renal transplant recipients
|
Rodrigo, E. |
|
2001 |
33 |
7-8 |
p. 3676- 1 p. |
artikel |
100 |
Effect of cyclosporine and ischemia on experimental transplant arteriosclerosis
|
Domı́nguez, J. |
|
2001 |
33 |
7-8 |
p. 3735-3736 2 p. |
artikel |
101 |
Effect of donor age on the outcome of one hla-haplotype mismatched living-related transplantation
|
Kim, Y.W. |
|
2001 |
33 |
7-8 |
p. 3793-3794 2 p. |
artikel |
102 |
Effect of donor hepatitis c on liver graft survival
|
Velidedeoglu, E. |
|
2001 |
33 |
7-8 |
p. 3795-3796 2 p. |
artikel |
103 |
Effect of ERL080A, RAD, and neoral on hamster-to-rat heart xenograft survival
|
Zhu, T. |
|
2001 |
33 |
7-8 |
p. 3871-3872 2 p. |
artikel |
104 |
Effects of exercise training on specific immune parameters in transplant recipients
|
Surgit, O. |
|
2001 |
33 |
7-8 |
p. 3298- 1 p. |
artikel |
105 |
Effects of mycophenolate mofetil and azathioprine on the erythropoietin production in renal transplant recipients
|
Montanaro, D |
|
2001 |
33 |
7-8 |
p. 3253-3255 3 p. |
artikel |
106 |
Effects of mycophenolate mofetil in the development of systemic lupus erythematosus in (NZBxNZW)F1 mice
|
Ramos, Ma.A. |
|
2001 |
33 |
7-8 |
p. 3316-3317 2 p. |
artikel |
107 |
Effects of pirfenidone on vascular smooth muscle cell proliferation and intimal hyperplasia following arterial balloon injury
|
Waller, J.R |
|
2001 |
33 |
7-8 |
p. 3816-3818 3 p. |
artikel |
108 |
Efficacy and safety of antithymocyte globulin treatment of steroid-resistant acute rejection in kidney transplantation
|
Bertoni, E. |
|
2001 |
33 |
7-8 |
p. 3337- 1 p. |
artikel |
109 |
Efficacy of C2 monitoring of cyclosporine neoral in adult liver transplantation: a comparative study
|
Santoyo, J. |
|
2001 |
33 |
7-8 |
p. 3096-3097 2 p. |
artikel |
110 |
Emergency intra- and perioperative doppler after kidney transplantation—a guide for immediate surgical intervention
|
Urbanc̆ic̆, A. |
|
2001 |
33 |
7-8 |
p. 3320-3321 2 p. |
artikel |
111 |
Enteric-coated mycophenolate sodium: results of two pivotal global multicenter trials
|
Granger, D.K |
|
2001 |
33 |
7-8 |
p. 3241-3244 4 p. |
artikel |
112 |
Enteric coating of mycophenolate sodium: a rational approach to limit topical gastrointestinal lesions and extend the therapeutic index of mycophenolate
|
Bjarnason, I. |
|
2001 |
33 |
7-8 |
p. 3238-3240 3 p. |
artikel |
113 |
Enzymatic digestion of α-gal antigens in pig organs by in vivo infusion of endo-β-galactosidase C
|
Kobayashi, T. |
|
2001 |
33 |
7-8 |
p. 3855-3856 2 p. |
artikel |
114 |
Erythrocyte sodium lithium countertransport in heart transplantation
|
Vareesangthip, K |
|
2001 |
33 |
7-8 |
p. 3561-3563 3 p. |
artikel |
115 |
Evaluation with enzyme-linked immunosorbent assay spot detection of the frequency of interferon-gamma-producing T cells in bronchoalveolar lavage is useful in identifying lung transplant patients at higher risk of acute rejection
|
Meloni, F. |
|
2001 |
33 |
7-8 |
p. 3286-3288 3 p. |
artikel |
116 |
Experience with basiliximab in pediatric liver graft recipients
|
Ganschow, R. |
|
2001 |
33 |
7-8 |
p. 3606-3607 2 p. |
artikel |
117 |
Factors influencing the discrepancy between donor and recipient glomerular filtration rate in kidney transplantation
|
Arisi, L. |
|
2001 |
33 |
7-8 |
p. 3377-3378 2 p. |
artikel |
118 |
Feasibility of changing therapeutic cyclosporine monitoring from C0 to C2 in stable renal recipients: narrower coefficient of variation with C2 monitoring
|
Chueh, S.-C. |
|
2001 |
33 |
7-8 |
p. 3100-3101 2 p. |
artikel |
119 |
First european combined heart, kidney, and pancreas transplantation 11 years after
|
Mettauer, B. |
|
2001 |
33 |
7-8 |
p. 3496-3498 3 p. |
artikel |
120 |
Flow panel reactive antibody monitoring following heart transplantation
|
Tambur, A.R. |
|
2001 |
33 |
7-8 |
p. 3295-3297 3 p. |
artikel |
121 |
FTY720: a new dimension in transplantation
|
Kahan, B.D. |
|
2001 |
33 |
7-8 |
p. 3081-3083 3 p. |
artikel |
122 |
FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines
|
Chen, S |
|
2001 |
33 |
7-8 |
p. 3057-3063 7 p. |
artikel |
123 |
FTY720: dissection of membrane receptor-operated, stereospecific effects on cell migration from receptor-independent antiproliferative and apoptotic effects
|
Brinkmann, V. |
|
2001 |
33 |
7-8 |
p. 3078-3080 3 p. |
artikel |
124 |
Functional reserve and hyperfiltration after cadaveric renal transplantation
|
Bertoni, E. |
|
2001 |
33 |
7-8 |
p. 3363-3364 2 p. |
artikel |
125 |
Further suppression of immune response in renal allograft recipients infected with hepatitis C
|
Rao, V.K |
|
2001 |
33 |
7-8 |
p. 3645- 1 p. |
artikel |
126 |
β-Galactosidase as a novel marker of ischaemic injury and a mechanism for viability assessment in liver transplantation
|
St. Peter, S.D. |
|
2001 |
33 |
7-8 |
p. 3753-3755 3 p. |
artikel |
127 |
Gene expression patterns in lung rejection
|
Hertz, M.I. |
|
2001 |
33 |
7-8 |
p. 3566-3567 2 p. |
artikel |
128 |
Generally increased, circulating endothelin can normalize after heart transplantation
|
Piquard, F |
|
2001 |
33 |
7-8 |
p. 3558-3560 3 p. |
artikel |
129 |
Genetic modification for xenotransplantation: transgenics and clones
|
d’Apice, A.J.F |
|
2001 |
33 |
7-8 |
p. 3053-3054 2 p. |
artikel |
130 |
Glucose intolerance and diabetes in recipients of kidney graft: comparison of old and new ADA and WHO criteria
|
Aragona, M |
|
2001 |
33 |
7-8 |
p. 3664- 1 p. |
artikel |
131 |
GLY145ARG mutation emerging under HBIG treatment in patients with recurrent HBV after liver transplantation strongly reduces viral secretion
|
Fischer, L. |
|
2001 |
33 |
7-8 |
p. 3633-3636 4 p. |
artikel |
132 |
Glycine reduces reperfusion injury in human liver transplantation: our first patients
|
Schemmer, P |
|
2001 |
33 |
7-8 |
p. 3750-3752 3 p. |
artikel |
133 |
Graft endothelium and chronic allograft nephropathy: insight from in vitro trans-differentiation of smooth muscle cells induced by mismatched lymphocytes
|
Amore, A. |
|
2001 |
33 |
7-8 |
p. 3347-3348 2 p. |
artikel |
134 |
Graft loss and death: changing causes after kidney transplantation
|
Howard, R.J. |
|
2001 |
33 |
7-8 |
p. 3416- 1 p. |
artikel |
135 |
Graft vascular endothelium: its role in transplantation biology
|
Paul, L.C. |
|
2001 |
33 |
7-8 |
p. 3809-3810 2 p. |
artikel |
136 |
Granzyme B inhibitor I reduces apoptotic cell death of allogeneic-transplanted hepatocytes in spleen
|
Song, E |
|
2001 |
33 |
7-8 |
p. 3274-3275 2 p. |
artikel |
137 |
Growth following solid organ transplantation
|
Fine, R.N. |
|
2001 |
33 |
7-8 |
p. 3592-3594 3 p. |
artikel |
138 |
Heart-lung-liver transplant for cystic fibrosis
|
Wise, P.E |
|
2001 |
33 |
7-8 |
p. 3568-3571 4 p. |
artikel |
139 |
Hepatic outflow insults in living-related liver transplantation: by doppler sonography
|
Huang, T.L. |
|
2001 |
33 |
7-8 |
p. 3464-3465 2 p. |
artikel |
140 |
Hepatocyte grafting as an alternative to liver transplant
|
Carraresi, L. |
|
2001 |
33 |
7-8 |
p. 3474-3476 3 p. |
artikel |
141 |
HIV infection following transplantation: the South African experience
|
Kahn, D. |
|
2001 |
33 |
7-8 |
p. 3649-3650 2 p. |
artikel |
142 |
HLA-DMB polymorphism in living-related kidney transplantation
|
Fukuda, Y |
|
2001 |
33 |
7-8 |
p. 3304-3308 5 p. |
artikel |
143 |
HLA-identical renal transplant recipients: immunosuppression, long-term complications, and survival
|
Peddi, V.R. |
|
2001 |
33 |
7-8 |
p. 3411-3413 3 p. |
artikel |
144 |
Hyperhomocysteinemia in renal transplant patients as independent cause of endothelial damage and cardiovascular disease
|
Bertoni, E |
|
2001 |
33 |
7-8 |
p. 3682-3683 2 p. |
artikel |
145 |
Immunomonitoring of renal transplant recipients in the early posttransplant period by analysis of cytokine gene expression in peripheral blood mononuclear cells
|
Gibbs, P.J. |
|
2001 |
33 |
7-8 |
p. 3285- 1 p. |
artikel |
146 |
Immunoregulatory T-Cells can mediate specific unresponsiveness to alloantigens in vivo
|
Wood, K.J. |
|
2001 |
33 |
7-8 |
p. 3829-3830 2 p. |
artikel |
147 |
Immunosuppression and bone loss after transplantation
|
Torregrosa, J.V. |
|
2001 |
33 |
7-8 |
p. 3665-3667 3 p. |
artikel |
148 |
Immunosuppression through blockade of transferrin receptor: mechanisms
|
Rastellini, C. |
|
2001 |
33 |
7-8 |
p. 3279- 1 p. |
artikel |
149 |
Incidence and treatment of hyperhomocysteinemia after renal transplantation
|
Zantvoort, F.A. |
|
2001 |
33 |
7-8 |
p. 3679-3680 2 p. |
artikel |
150 |
Increasing incidence of cytomegalovirus disease in indian renal transplant recipients on cyclosporine immunosuppression
|
Sakhuja, V. |
|
2001 |
33 |
7-8 |
p. 3631-3632 2 p. |
artikel |
151 |
Induction versus noninduction protocols in anti-calcineurin-based immunosuppression
|
Charpentier, B. |
|
2001 |
33 |
7-8 |
p. 3334-3336 3 p. |
artikel |
152 |
Influence of Ginkgo Biloba extract (EGB 761) on expression of EGR-1 mRNA and HSP-70 mRNA after warm ischemia in the rat liver
|
Schutte, A. |
|
2001 |
33 |
7-8 |
p. 3724-3725 2 p. |
artikel |
153 |
Influence of recipient and donor age on long-term renal allograft function in an experimental model
|
Tullius, S.G. |
|
2001 |
33 |
7-8 |
p. 3345-3346 2 p. |
artikel |
154 |
Initial neoral use for living-related partial liver transplantation: Its indication and limitation
|
Yokoyama, I. |
|
2001 |
33 |
7-8 |
p. 3131-3132 2 p. |
artikel |
155 |
Insulin secretion from cultured islets encapsulated in immuno- and virus-protective capillaries
|
Petersen, P. |
|
2001 |
33 |
7-8 |
p. 3520-3522 3 p. |
artikel |
156 |
Interaction between acute rejection and recipient age on long-term renal allograft survival
|
Meier-Kriesche, H.-U. |
|
2001 |
33 |
7-8 |
p. 3425-3426 2 p. |
artikel |
157 |
Interleukin-2R antagonists in the prevention of acute rejection in living donor transplantation
|
Ivanovski, N. |
|
2001 |
33 |
7-8 |
p. 3203-3204 2 p. |
artikel |
158 |
Interleukin-2 receptor monoclonal antibodies in renal transplantation: current use and emerging regimens
|
Vincenti, F |
|
2001 |
33 |
7-8 |
p. 3169-3171 3 p. |
artikel |
159 |
Intestinal biotransformation of cyclosporine A in an extracorporeal pig intestine perfusion model
|
Braun, F |
|
2001 |
33 |
7-8 |
p. 3154-3155 2 p. |
artikel |
160 |
Investigation of the relationship between maintenance dose of cyclosporine and nephrotoxicity or hypertension
|
Opelz, G. |
|
2001 |
33 |
7-8 |
p. 3351-3354 4 p. |
artikel |
161 |
In vitro functional assessment of a porcine hepatocytes based bioartificial liver
|
Donini, A. |
|
2001 |
33 |
7-8 |
p. 3477-3479 3 p. |
artikel |
162 |
Is losartan as effective as enalapril on posttransplant persistent proteinuria?
|
Altiparmak, M.R |
|
2001 |
33 |
7-8 |
p. 3368-3369 2 p. |
artikel |
163 |
Is transjugular intrahepatic portosystemic shunt really deleterious for liver transplantation issue? a monocentric study on 86 liver transplanted patients
|
Castellani, P. |
|
2001 |
33 |
7-8 |
p. 3468-3469 2 p. |
artikel |
164 |
Is transplantion of two HLA DR mismatched living-donor kidneys justifiable?
|
Ozmen, M.M |
|
2001 |
33 |
7-8 |
p. 3407-3408 2 p. |
artikel |
165 |
Kaposi sarcoma: an analysis of the US and international experiences from the Israel Penn international transplant tumor registry
|
Woodle, E.S. |
|
2001 |
33 |
7-8 |
p. 3660-3661 2 p. |
artikel |
166 |
Kidney transplantation from non-heart-beating donors 1 1 Cadaver donor
|
Nicholson, M.L |
|
2001 |
33 |
7-8 |
p. 3756-3758 3 p. |
artikel |
167 |
Laparoscopic kidney harvesting for living donor kidney transplantation—one year follow-up of the initial 15 patients
|
Giessing, M. |
|
2001 |
33 |
7-8 |
p. 3791-3792 2 p. |
artikel |
168 |
Laparoscopic live donor nephrectomy: a comparison with the open operation
|
Waller, J.R. |
|
2001 |
33 |
7-8 |
p. 3787-3788 2 p. |
artikel |
169 |
Late failures in renal transplant recipients under cyclosporine treatment
|
Ponticelli, C. |
|
2001 |
33 |
7-8 |
p. 3325-3326 2 p. |
artikel |
170 |
Leukocyte phagocytosis is impaired during kidney xenotransplantation
|
Jaeger, K. |
|
2001 |
33 |
7-8 |
p. 3869-3870 2 p. |
artikel |
171 |
Leukocyte phenotype and function predicts infection risk in renal transplant recipients
|
Blazic, M. |
|
2001 |
33 |
7-8 |
p. 3651- 1 p. |
artikel |
172 |
Liver retransplantations with split in situ grafts in pediatric recipients
|
Maggi, U. |
|
2001 |
33 |
7-8 |
p. 3614- 1 p. |
artikel |
173 |
Liver transplantation in children with alagille syndrome
|
Ganschow, R. |
|
2001 |
33 |
7-8 |
p. 3608-3609 2 p. |
artikel |
174 |
Liver transplantation today
|
Klempnauer, J. |
|
2001 |
33 |
7-8 |
p. 3433-3435 3 p. |
artikel |
175 |
Liver transplantation using a 93-year-old donor
|
Romagnoli, J. |
|
2001 |
33 |
7-8 |
p. 3797- 1 p. |
artikel |
176 |
Living donor liver transplantation: a critical review
|
Emre, S. |
|
2001 |
33 |
7-8 |
p. 3456-3457 2 p. |
artikel |
177 |
Living donor lung transplantation: selection, technique, and outcome
|
Barr, M.L. |
|
2001 |
33 |
7-8 |
p. 3527-3532 6 p. |
artikel |
178 |
Living orthotopic liver transplant using right lobe: our experience in the first 19 donors
|
Cuomo, O. |
|
2001 |
33 |
7-8 |
p. 3801-3802 2 p. |
artikel |
179 |
Long-term effects of chronic cyclosporine nephropathy on outcome of renal allografts
|
Takeda, A. |
|
2001 |
33 |
7-8 |
p. 3379-3380 2 p. |
artikel |
180 |
Long-term effects of single versus double CsA dosing in kidney transplantation
|
Tarantino, A. |
|
2001 |
33 |
7-8 |
p. 3409-3410 2 p. |
artikel |
181 |
Long-term follow up of renal transplant artery stenosis by doppler
|
Buturović-Ponikvar, J |
|
2001 |
33 |
7-8 |
p. 3390-3391 2 p. |
artikel |
182 |
Long-term outcome of cadaver kidney transplants from non-heart-beating donors
|
Ohshima, S. |
|
2001 |
33 |
7-8 |
p. 3764-3768 5 p. |
artikel |
183 |
Long-term results of 211 single necrokidney transplantations from extreme-age donors: why dual allograft?
|
Berardinelli, L |
|
2001 |
33 |
7-8 |
p. 3774-3776 3 p. |
artikel |
184 |
Long-term results of spousal renal donor transplants with donor-specific blood transfusions
|
Miura, S |
|
2001 |
33 |
7-8 |
p. 3417-3419 3 p. |
artikel |
185 |
Long-term surveillance of heart-transplanted patients: noninvasive monitoring of acute rejection episodes and transplant vasculopathy
|
Hummel, M |
|
2001 |
33 |
7-8 |
p. 3539-3542 4 p. |
artikel |
186 |
Low-dose immunosuppression with FK 506 and sirolimus after liver transplantation: 1-year results
|
Pridöhl, O. |
|
2001 |
33 |
7-8 |
p. 3229-3231 3 p. |
artikel |
187 |
Low-dose sirolimus and tacrolimus in kidney transplantation: first results of a single-center experience
|
Hartwig, T. |
|
2001 |
33 |
7-8 |
p. 3226-3228 3 p. |
artikel |
188 |
Low rate of acute rejection and cytomegalovirus infection in kidney transplant recipients with basiliximab
|
Folkmane, I. |
|
2001 |
33 |
7-8 |
p. 3209-3210 2 p. |
artikel |
189 |
Malignant neoplastic disorders following long-term immunosuppression after orthotopic heart transplantation
|
Tenderich, G. |
|
2001 |
33 |
7-8 |
p. 3653-3655 3 p. |
artikel |
190 |
Measuring intrarenal vascular resistance during machine perfusion preservation does not improve the assessment of renal viability made on clinical grounds
|
Metcalfe, M.S. |
|
2001 |
33 |
7-8 |
p. 3745-3746 2 p. |
artikel |
191 |
Mechanism of action of the calcineurin inhibitors
|
Halloran, P.F. |
|
2001 |
33 |
7-8 |
p. 3067-3069 3 p. |
artikel |
192 |
Medical evaluation for pancreas transplantation: evolving concepts
|
Pirsch, J.D. |
|
2001 |
33 |
7-8 |
p. 3489-3491 3 p. |
artikel |
193 |
Molecular adsorbant recirculating system in patients with liver failure
|
Lamesch, P. |
|
2001 |
33 |
7-8 |
p. 3480-3482 3 p. |
artikel |
194 |
Monoclonal antibody basiliximab with low cyclosporine dose as initial immunosuppression
|
Boletis, J.N |
|
2001 |
33 |
7-8 |
p. 3184-3186 3 p. |
artikel |
195 |
Morbidity, mortality beyond the 10th year following heart transplant: data from a population of 163 patients
|
Sebbag, L |
|
2001 |
33 |
7-8 |
p. 3551-3552 2 p. |
artikel |
196 |
Mycophenolate mofetil conversion or addition in patients with chronic progressive deterioration of renal allograft function
|
Altaca, G. |
|
2001 |
33 |
7-8 |
p. 3248-3249 2 p. |
artikel |
197 |
Myocardial Na+/K+-ATPases and systolic heart hailure after transplantation
|
Tran, N |
|
2001 |
33 |
7-8 |
p. 3555-3557 3 p. |
artikel |
198 |
Neoral-based immunosuppression in living donor liver transplantation
|
Takatsuki, M. |
|
2001 |
33 |
7-8 |
p. 3450- 1 p. |
artikel |
199 |
Neoral C2 in liver transplant recipients
|
Levy, G.A |
|
2001 |
33 |
7-8 |
p. 3089-3091 3 p. |
artikel |
200 |
Neoral C2 monitoring in pediatric liver transplant recipients
|
Dunn, S. |
|
2001 |
33 |
7-8 |
p. 3094-3095 2 p. |
artikel |
201 |
Neoral dose monitoring with cyclosporine 2-hour postdose levels (C2) in different renal transplant patient age groups
|
Rosati, A. |
|
2001 |
33 |
7-8 |
p. 3106-3107 2 p. |
artikel |
202 |
Neoral drug monitoring in stable kidney allotransplant recipients: C0 versus C2
|
Lukaschek, J. |
|
2001 |
33 |
7-8 |
p. 3104-3105 2 p. |
artikel |
203 |
New approaches to paediatric liver transplantation
|
Kelly, D.A. |
|
2001 |
33 |
7-8 |
p. 3602-3603 2 p. |
artikel |
204 |
New developments in pancreas and islet transplantation
|
Squifflet, J.-P. |
|
2001 |
33 |
7-8 |
p. 3492-3493 2 p. |
artikel |
205 |
New frontiers: adult to adult living donor liver transplantation, single center experience from turkey
|
Tokat, Y. |
|
2001 |
33 |
7-8 |
p. 3458-3460 3 p. |
artikel |
206 |
New immunosuppressive regimens and cytomegalovirus infection after kidney transplantation: a retrospective study
|
Côté, I |
|
2001 |
33 |
7-8 |
p. 3626-3629 4 p. |
artikel |
207 |
Newly developing proteinuria but not blood pressure is an independent risk factor for chronic graft dysfunction following renal transplantation in patients with well-controlled blood pressure
|
Braun, N. |
|
2001 |
33 |
7-8 |
p. 3361-3362 2 p. |
artikel |
208 |
New trends in heart transplantation
|
Gambino, A. |
|
2001 |
33 |
7-8 |
p. 3536-3538 3 p. |
artikel |
209 |
NF-κB antisense oligonucleotides reduce leukocyte-endothelial interaction in hepatic ischemia-reperfusion
|
Banafsche, R |
|
2001 |
33 |
7-8 |
p. 3726-3727 2 p. |
artikel |
210 |
NKT Cells as nonspecific immune-regulator inducing tolerance in mouse model transplantation
|
Chargui, J. |
|
2001 |
33 |
7-8 |
p. 3833-3834 2 p. |
artikel |
211 |
Normothermic perfusion of ischaemically damaged porcine kidneys: an evaluation of ex vivo function
|
Metcalfe, M.S. |
|
2001 |
33 |
7-8 |
p. 3743-3744 2 p. |
artikel |
212 |
Normothermic perfusion of the isolated liver
|
Friend, P.J. |
|
2001 |
33 |
7-8 |
p. 3436-3438 3 p. |
artikel |
213 |
Nutritional status in renal transplant recipients, evaluated by means of body composition analysis
|
Lucchesi, A. |
|
2001 |
33 |
7-8 |
p. 3398-3399 2 p. |
artikel |
214 |
Obese kidney transplant recipients have good outcomes
|
Howard, R.J |
|
2001 |
33 |
7-8 |
p. 3420-3421 2 p. |
artikel |
215 |
Optimal time for determination of blood tacrolimus level
|
Jørgensen, K.A. |
|
2001 |
33 |
7-8 |
p. 3164-3165 2 p. |
artikel |
216 |
Optimization of cyclosporine exposure utilizing C2 level monitoring in de novo renal transplant recipients: the toronto general hospital experience
|
Maham, N. |
|
2001 |
33 |
7-8 |
p. 3098-3099 2 p. |
artikel |
217 |
Optimization of cyclosporine therapy in the neoral era: abbreviated AUC, single blood sampling?
|
Gaspari, F. |
|
2001 |
33 |
7-8 |
p. 3117-3119 3 p. |
artikel |
218 |
Optimizing neoral therapeutic drug monitoring with cyclosporine trough (C0) and C2 concentrations in stable renal allograft recipients
|
Einecke, G |
|
2001 |
33 |
7-8 |
p. 3102-3103 2 p. |
artikel |
219 |
Outcome of renal transplants in patients with IgA nephropathy
|
Koselj-Kajtna, M. |
|
2001 |
33 |
7-8 |
p. 3429-3430 2 p. |
artikel |
220 |
Overseas procurement of donor hearts: ischemic time effect on postoperative outcomes
|
Fernandez, J |
|
2001 |
33 |
7-8 |
p. 3803-3804 2 p. |
artikel |
221 |
Oxygen profile of microencapsulated islets: effect of immobilised hemoglobin in the alginate matrix
|
Schrezenmeir, J |
|
2001 |
33 |
7-8 |
p. 3511-3516 6 p. |
artikel |
222 |
Pancreas and islet transplantation: an unfinished journey
|
Allen, R.D.M. |
|
2001 |
33 |
7-8 |
p. 3485-3488 4 p. |
artikel |
223 |
Pancreas transplantation in Asan Medical Center, Korea
|
Han, D.J. |
|
2001 |
33 |
7-8 |
p. 3499- 1 p. |
artikel |
224 |
Partial splenic embolization for hypersplenism after liver transplantation
|
Sockrider, C.S. |
|
2001 |
33 |
7-8 |
p. 3472-3473 2 p. |
artikel |
225 |
Pathologic characteristics of acute humoral rejection after abo-incompatible kidney transplantation
|
Morozumi, K. |
|
2001 |
33 |
7-8 |
p. 3299-3300 2 p. |
artikel |
226 |
Pediatric renal transplantation
|
Harmon, W. |
|
2001 |
33 |
7-8 |
p. 3585-3586 2 p. |
artikel |
227 |
Pediatric renal transplantation: experience from a center in central Anatolia
|
Duzova, A. |
|
2001 |
33 |
7-8 |
p. 3597-3598 2 p. |
artikel |
228 |
Perioperative donor bone marrow infusion in cadaver kidney transplant recipients
|
Garcia-Morales, R.O. |
|
2001 |
33 |
7-8 |
p. 3840-3843 4 p. |
artikel |
229 |
Persistent hyperglycemia in pediatric liver transplant recipients
|
Romero, R. |
|
2001 |
33 |
7-8 |
p. 3617-3618 2 p. |
artikel |
230 |
Pharmacodynamic monitoring of lymphocyte proliferation and TGF-β1 expression at cyclosporine a (CyA) trough levels (C0) and 2 hours after intake (C2) of CyA in human renal allograft recipients
|
Böhler, T. |
|
2001 |
33 |
7-8 |
p. 3148-3150 3 p. |
artikel |
231 |
Pharmacodynamic monitoring of mycophenolate mofetil in renal allograft recipients
|
Budde, K. |
|
2001 |
33 |
7-8 |
p. 3313-3315 3 p. |
artikel |
232 |
Pharmacoeconomic evaluation of simulect prophylaxis in renal transplant recipients
|
Walters, S.J |
|
2001 |
33 |
7-8 |
p. 3187-3191 5 p. |
artikel |
233 |
Pharmacokinetics and pharmacodynamics of a chimeric interleukin-2 receptor monoclonal antibody, basiliximab, in renal transplantation: a comparison between Japanese and non-Japanese patients
|
Haba, T. |
|
2001 |
33 |
7-8 |
p. 3174-3175 2 p. |
artikel |
234 |
Phosphorothioate/methoxyethyl-modified ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury 1 1 Renal
|
Stepkowski, S.M. |
|
2001 |
33 |
7-8 |
p. 3705-3706 2 p. |
artikel |
235 |
Physiologic regulation of alloimmune responses in vivo: the role of CTLA4 and TH1/TH2 cytokines
|
Sho, M. |
|
2001 |
33 |
7-8 |
p. 3826-3828 3 p. |
artikel |
236 |
PNU156804 inhibits Jak3 tyrosine kinase and rat heart allograft rejection
|
Stepkowski, S.M. |
|
2001 |
33 |
7-8 |
p. 3272-3273 2 p. |
artikel |
237 |
Posttransplant diabetes mellitus in renal allograft recipients
|
Koselj, M. |
|
2001 |
33 |
7-8 |
p. 3662-3663 2 p. |
artikel |
238 |
Preemptive oral ganciclovir therapy versus prophylaxis to prevent symptomatic cytomegalovirus infection after kidney transplantation
|
Jung, C |
|
2001 |
33 |
7-8 |
p. 3621-3623 3 p. |
artikel |
239 |
Pretreatment with magnolol attenuates ischemia-reperfusion injury in rat small intestine
|
Loong, C.C. |
|
2001 |
33 |
7-8 |
p. 3737-3738 2 p. |
artikel |
240 |
Prevention of hyperacute rejection of pig-to-monkey cardiac xenografts by chinese cobra venom factor
|
Chen, G. |
|
2001 |
33 |
7-8 |
p. 3857-3858 2 p. |
artikel |
241 |
Primary nonfunctioning graft in cadaveric renal transplantation
|
Castilho, C. |
|
2001 |
33 |
7-8 |
p. 3785-3786 2 p. |
artikel |
242 |
Prognosis in patients with primary pulmonary hypertension awaiting lung transplantation
|
Ewert, R. |
|
2001 |
33 |
7-8 |
p. 3574-3575 2 p. |
artikel |
243 |
Progression of chronic renal transplant dysfunction
|
Fellström, B. |
|
2001 |
33 |
7-8 |
p. 3355-3356 2 p. |
artikel |
244 |
Prospective analysis and successful treatment of thrombotic microangiopathy in renal allografts under tacrolimus immunosuppression
|
Tanabe, K |
|
2001 |
33 |
7-8 |
p. 3688-3690 3 p. |
artikel |
245 |
Prostaglandin E1 inhibits cyclosporine A-induced upregulation of transforming growth factor-beta 1 in rat mesangial cells
|
Dell, K. |
|
2001 |
33 |
7-8 |
p. 3342-3344 3 p. |
artikel |
246 |
Protective effect of a selective endothelin a receptor antagonist (BSF 208075) on graft pancreatitis in pig pancreas transplantation
|
Uhlmann, D |
|
2001 |
33 |
7-8 |
p. 3732-3734 3 p. |
artikel |
247 |
Protective Effects of Polyethylene Glycol (20 mol/L) in Phosphate-Buffered Sucrose for Rat Liver Preservation
|
Ahmed, I |
|
2001 |
33 |
7-8 |
p. 3713-3715 3 p. |
artikel |
248 |
Proteinuria as a useful clinical marker of cyclosporine nephrotoxicity in renal transplant patients
|
Fernández-Fresnedo, G |
|
2001 |
33 |
7-8 |
p. 3373-3374 2 p. |
artikel |
249 |
Proteinuria at five years after kidney transplantation: the role of anti-HCV-positive state
|
Virgilio, B. |
|
2001 |
33 |
7-8 |
p. 3639-3640 2 p. |
artikel |
250 |
Psychiatric complications after liver transplantation
|
Kizilisik, A.T. |
|
2001 |
33 |
7-8 |
p. 3697- 1 p. |
artikel |
251 |
Psychiatric symptoms in renal transplant patients in relation to alexithymia
|
Kubo, M. |
|
2001 |
33 |
7-8 |
p. 3698-3699 2 p. |
artikel |
252 |
Purity of alginate affects the viability and fibrotic overgrowth of encapsulated porcine islet xenografts
|
Zhang, W.J. |
|
2001 |
33 |
7-8 |
p. 3517-3519 3 p. |
artikel |
253 |
Pyruvate improves pancreatic islet engraftment and functionality
|
Brown, M. |
|
2001 |
33 |
7-8 |
p. 3523- 1 p. |
artikel |
254 |
Quality of life after heart and heart-lung transplantation
|
Hummel, M |
|
2001 |
33 |
7-8 |
p. 3546-3548 3 p. |
artikel |
255 |
Quality of life for renal transplant recipients of organs from non-heart-beating donors, heart-beating cadaveric donors, and living-related donors
|
Metcalfe, M.S |
|
2001 |
33 |
7-8 |
p. 3403-3404 2 p. |
artikel |
256 |
Quality of life of pediatric patients receiving living donor liver transplantation in long-term follow-up period
|
Ohkohchi, N. |
|
2001 |
33 |
7-8 |
p. 3610-3613 4 p. |
artikel |
257 |
Rapamycin reduces rejection in heart transplant recipients
|
Radovancevic, B. |
|
2001 |
33 |
7-8 |
p. 3221-3222 2 p. |
artikel |
258 |
Recipient age affects chronic allograft nephropathy in rats
|
Wang, M. |
|
2001 |
33 |
7-8 |
p. 3341- 1 p. |
artikel |
259 |
Refining immunosuppressive protocols in pediatric renal transplant recipients
|
Hoyer, P.F. |
|
2001 |
33 |
7-8 |
p. 3587-3589 3 p. |
artikel |
260 |
Renal allograft surveillance by mRNA profiling of urinary cells
|
Li, B |
|
2001 |
33 |
7-8 |
p. 3280-3282 3 p. |
artikel |
261 |
Renal function after liver transplantation
|
Bäckman, L |
|
2001 |
33 |
7-8 |
p. 3442-3443 2 p. |
artikel |
262 |
Renal transplantation from marginal donors: results and allocation strategies
|
Persson, N.H. |
|
2001 |
33 |
7-8 |
p. 3759-3761 3 p. |
artikel |
263 |
Renal transplantation from older donors
|
Tarantino, A |
|
2001 |
33 |
7-8 |
p. 3769-3770 2 p. |
artikel |
264 |
Renal transplantation in amyloidosis secondary to familial Mediterranean fever
|
Sever, M.S. |
|
2001 |
33 |
7-8 |
p. 3392-3393 2 p. |
artikel |
265 |
Renal transplantation in children less than six years old
|
Garcia, C.D. |
|
2001 |
33 |
7-8 |
p. 3595-3596 2 p. |
artikel |
266 |
Renal transplantation with simulect (basiliximab) plus sandimmune neoral-based immunosuppression: a report of 41 cases in Taiwan
|
Tsai, M.K. |
|
2001 |
33 |
7-8 |
p. 3194- 1 p. |
artikel |
267 |
Reversal of streptozotocin-diabetes after transplantation of piscine principal islets to nude mice
|
Laue, C |
|
2001 |
33 |
7-8 |
p. 3504-3510 7 p. |
artikel |
268 |
Risk factors that influence the intercept or the slope of graft function over time
|
Paul, L.C. |
|
2001 |
33 |
7-8 |
p. 3359-3360 2 p. |
artikel |
269 |
Role of ACE gene polymorphism on cardiovascular complications after renal transplantation
|
Hernández, D |
|
2001 |
33 |
7-8 |
p. 3686-3687 2 p. |
artikel |
270 |
Role of ischemia-reperfusion injury in the development of chronic renal allograft damage
|
Grinyo, J.M. |
|
2001 |
33 |
7-8 |
p. 3741-3742 2 p. |
artikel |
271 |
Serum antibody activity to glomerular endothelial cells is a useful indication for renal allograft rejection
|
Nakagawa, Y. |
|
2001 |
33 |
7-8 |
p. 3289-3292 4 p. |
artikel |
272 |
Seventeen adult-to-adult living donor liver transplantations using dual grafts
|
Lee, S.G |
|
2001 |
33 |
7-8 |
p. 3461-3463 3 p. |
artikel |
273 |
Severe neurotoxicity of tacrolimus (FK506) after renal transplantation: two case reports
|
Scheel, A.K. |
|
2001 |
33 |
7-8 |
p. 3693-3694 2 p. |
artikel |
274 |
Short-term outcome of dual kidney transplantation at a single center
|
Rigotti, P |
|
2001 |
33 |
7-8 |
p. 3771-3773 3 p. |
artikel |
275 |
Simulect, calcineurin inhibitor, mycophenolate mofetil, and prednisone is more effective than OKT3, calcineurin inhibitor, hycophendate mofetil, and prednisone in African American kidney recipients in reducing acute rejections and prolonging graft survival
|
Kumar, A.M.S |
|
2001 |
33 |
7-8 |
p. 3195-3196 2 p. |
artikel |
276 |
Simulect, neoral, cellcept, and prednisone in kidney recipients with delayed graft function: a prospective controlled study
|
Kumar, M.S.A |
|
2001 |
33 |
7-8 |
p. 3762-3763 2 p. |
artikel |
277 |
Simultaneous pancreas-kidney transplant compared with kidney transplant in Type I diabetic patients with end-stage renal disease
|
Pérez, R. |
|
2001 |
33 |
7-8 |
p. 3494-3495 2 p. |
artikel |
278 |
Simultaneous transplantation model of the aorta and carotid in rats
|
Chen, Z.S. |
|
2001 |
33 |
7-8 |
p. 3824-3825 2 p. |
artikel |
279 |
Single-center experience with the “old for old” program for renal transplantation
|
Beckurts, U.T.E. |
|
2001 |
33 |
7-8 |
p. 3779-3780 2 p. |
artikel |
280 |
Single-center study utilizing C2 level as monitoring tool in de novo renal transplant recipients treated with neoral
|
Keshavamurthy, M. |
|
2001 |
33 |
7-8 |
p. 3112-3114 3 p. |
artikel |
281 |
Sirolimus and low-dose tacrolimus with antibody induction in kidney transplantation: preliminary results of a pilot study
|
Lawen, J |
|
2001 |
33 |
7-8 |
p. 3223-3225 3 p. |
artikel |
282 |
Solid organ transplantation in HIV-positive patients
|
Stock, P. |
|
2001 |
33 |
7-8 |
p. 3646-3648 3 p. |
artikel |
283 |
Steps toward transplantation tolerance in the clinic
|
Knechtle, S.J. |
|
2001 |
33 |
7-8 |
p. 3844-3845 2 p. |
artikel |
284 |
Steroid-free immunosuppression
|
Ponticelli, C. |
|
2001 |
33 |
7-8 |
p. 3259-3260 2 p. |
artikel |
285 |
Steroid withdrawal in long-term cyclosporine a treated patients using mycophenolate mofetil: a prospective randomized pilot study
|
Budde, K |
|
2001 |
33 |
7-8 |
p. 3250-3252 3 p. |
artikel |
286 |
Steroid withdrawal in long-term liver transplant recipients
|
Sterneck, M |
|
2001 |
33 |
7-8 |
p. 3265-3267 3 p. |
artikel |
287 |
Steroid withdrawal in renal transplanation
|
Hricik, D.E. |
|
2001 |
33 |
7-8 |
p. 3261-3262 2 p. |
artikel |
288 |
Steroid withdrawal in renal transplantation treated with cyclosporine a: long-term evolution
|
Gómez, E. |
|
2001 |
33 |
7-8 |
p. 3263-3264 2 p. |
artikel |
289 |
Study of simulect-based, steroid-free immunosuppressive regimen in HCV+ de novo liver transplant patients: preliminary results
|
Filipponi, F |
|
2001 |
33 |
7-8 |
p. 3211-3212 2 p. |
artikel |
290 |
Study of the cyclosporine concentration at 2 hours in stable renal transplant patients and relation to body mass index
|
Hortal, L |
|
2001 |
33 |
7-8 |
p. 3110-3111 2 p. |
artikel |
291 |
Successful hepatitis B reinfection prophylaxis with lamivudine and hepatitis B immune globulin in patients with positive HBV-DNA at time of liver transplantation
|
Rosenau, J. |
|
2001 |
33 |
7-8 |
p. 3637-3638 2 p. |
artikel |
292 |
Successful pediatric kidney transplantation from pediatric Non-Heart-Beating Donors
|
Saito, K. |
|
2001 |
33 |
7-8 |
p. 3781-3782 2 p. |
artikel |
293 |
Suppression of kupffer cell function is a key for liver transplantation from the non-heart-beating donor
|
Ohkohchi, N. |
|
2001 |
33 |
7-8 |
p. 3728-3731 4 p. |
artikel |
294 |
Surgical management of high-grade vesicoureteral reflux in renal transplant recipients
|
Kmetec, A. |
|
2001 |
33 |
7-8 |
p. 3383-3384 2 p. |
artikel |
295 |
Surgical options for live-donor nephrectomy
|
Velidedeoglu, E |
|
2001 |
33 |
7-8 |
p. 3789-3790 2 p. |
artikel |
296 |
Survival after liver transplantation for hepatocellular carcinoma in cirrhosis according to the underlying liver disease
|
Jonas, S. |
|
2001 |
33 |
7-8 |
p. 3444-3445 2 p. |
artikel |
297 |
Targeting Jak3 for immune suppression and allograft acceptance
|
Kirken, R.A. |
|
2001 |
33 |
7-8 |
p. 3268-3270 3 p. |
artikel |
298 |
T-cell apoptosis triggered by FTY720 via mitochondrial pathway
|
Fujino, M. |
|
2001 |
33 |
7-8 |
p. 3084-3085 2 p. |
artikel |
299 |
T-Cell-Mediated immune response is crucial for hamster-to-mouse cardiac xenograft rejection
|
Zhu, T. |
|
2001 |
33 |
7-8 |
p. 3823- 1 p. |
artikel |
300 |
Ten years of chronic immunosuppressive therapy following orthotopic liver transplantation: impact on health and quality of life
|
Kizilisik, A.T. |
|
2001 |
33 |
7-8 |
p. 3448-3449 2 p. |
artikel |
301 |
The Buffalo/Mna rat, an animal model of FSGS recurrence after renal transplantation
|
Le Berre, L. |
|
2001 |
33 |
7-8 |
p. 3338-3340 3 p. |
artikel |
302 |
The development of tacrolimus in renal transplantation
|
Shapiro, R. |
|
2001 |
33 |
7-8 |
p. 3158-3160 3 p. |
artikel |
303 |
The effect of kidney transplantation on autonomic nervous dysfunction in patients with chronic renal failure
|
Kveder, R |
|
2001 |
33 |
7-8 |
p. 3394-3395 2 p. |
artikel |
304 |
The effects of rejection episodes, obesity, and osteopenia on functional performance and health-related quality of life after heart transplantation
|
Streiff, N |
|
2001 |
33 |
7-8 |
p. 3533-3535 3 p. |
artikel |
305 |
The efficacy and safety of mizoribine in living donor kidney transplantation: a 24-week, open-label, prospective study (phase III clinical trial)
|
Cho, D.K. |
|
2001 |
33 |
7-8 |
p. 3256-3258 3 p. |
artikel |
306 |
The enigma of tolerance and chimerism: variable role of t cells and chimerism in induction of tolerance with bone marrow
|
Monaco, A.P. |
|
2001 |
33 |
7-8 |
p. 3837-3839 3 p. |
artikel |
307 |
The evolution of therapeutic drug monitoring of cyclosporine 1 1 Concentration monitoring
|
Kahan, B.D. |
|
2001 |
33 |
7-8 |
p. 3086-3088 3 p. |
artikel |
308 |
The evolving role of tor inhibitors for individualizing posttransplant immunosuppression
|
Lorber, M.I. |
|
2001 |
33 |
7-8 |
p. 3075-3077 3 p. |
artikel |
309 |
The α-gal analog GAS914 ameliorates delayed rejection of hDAF transgenic pig-to-baboon renal xenografts
|
Ghanekar, A. |
|
2001 |
33 |
7-8 |
p. 3853-3854 2 p. |
artikel |
310 |
The IL2 pathway in clinical immunosuppression
|
Nashan, B. |
|
2001 |
33 |
7-8 |
p. 3072-3074 3 p. |
artikel |
311 |
The matrix of clinical immunosuppression for transplantation
|
Kahan, B.D. |
|
2001 |
33 |
7-8 |
p. 3035-3037 3 p. |
artikel |
312 |
The new “impella” intracardiac microaxial pump for treatment of right heart failure after orthotopic heart transplantation
|
Martin, J. |
|
2001 |
33 |
7-8 |
p. 3549-3550 2 p. |
artikel |
313 |
The present status of xenotransplantation
|
Levy, G.A. |
|
2001 |
33 |
7-8 |
p. 3050-3052 3 p. |
artikel |
314 |
Therapeutic equivalence of mycophenolate sodium versus mycophenolate mofetil in de novo renal transplant recipients 1 1 For the ERLB301 Renal Transplant Study Group.
|
Salvadori, M |
|
2001 |
33 |
7-8 |
p. 3245-3247 3 p. |
artikel |
315 |
The role of adhesion molecules and chemokines in homeostasis and pathologic processes in transplanted organs
|
Stepkowski, S.M. |
|
2001 |
33 |
7-8 |
p. 3064-3066 3 p. |
artikel |
316 |
The role of certican (everolimus, rad) in the many pathways of chronic rejection
|
Nashan, B |
|
2001 |
33 |
7-8 |
p. 3215-3220 6 p. |
artikel |
317 |
The role of signals 1, 2, and 3 in induction of transplantation tolerance
|
Stepkowski, S.M. |
|
2001 |
33 |
7-8 |
p. 3831-3832 2 p. |
artikel |
318 |
The role of Stat5 in the induction of regulatory t cells in transplantation tolerance
|
Stepkowski, S.M. |
|
2001 |
33 |
7-8 |
p. 3835-3836 2 p. |
artikel |
319 |
The value of dynamic enhanced MRI in the early diagnosis of hip pain in patients having received marrow transplantation
|
Tan, C.F. |
|
2001 |
33 |
7-8 |
p. 3670-3671 2 p. |
artikel |
320 |
The value of renal resistive index for the detection of vesicoureteral reflux in renal transplant recipients
|
Kmetec, A |
|
2001 |
33 |
7-8 |
p. 3385-3387 3 p. |
artikel |
321 |
Three-hour postdose cyclosporine level monitoring: less rejection and more nephrotoxicity?
|
Domı́nguez, J. |
|
2001 |
33 |
7-8 |
p. 3120-3121 2 p. |
artikel |
322 |
Time to request ABO-identity when transplanting for fulminant hepatic failure?
|
Ericzon, B.-G |
|
2001 |
33 |
7-8 |
p. 3466-3467 2 p. |
artikel |
323 |
Tissue concentration of cytokines in kidneys from non-heart-beating donors
|
Tŕeška, V. |
|
2001 |
33 |
7-8 |
p. 3747-3749 3 p. |
artikel |
324 |
T-lymphocyte kinetics in acute rejection after orthotopic liver transplantation
|
Cuomo, O. |
|
2001 |
33 |
7-8 |
p. 3303- 1 p. |
artikel |
325 |
TNF:TNF-R T-Cell costimulatory pathways in transplantation
|
Yamada, A. |
|
2001 |
33 |
7-8 |
p. 3070-3071 2 p. |
artikel |
326 |
Transplantation of small en bloc kidneys including a horseshoe kidney from donors aged 2 to 60 months to adult recipients: a 13-year experience
|
Merkel, F.K |
|
2001 |
33 |
7-8 |
p. 3783-3784 2 p. |
artikel |
327 |
Transplantation tolerance—discussion
|
Wood, K.J. |
|
2001 |
33 |
7-8 |
p. 3819-3820 2 p. |
artikel |
328 |
Treatment of reccurence of focal segmental glomerular sclerosis after kidney transplantation with plasma exchange and immunoadsorption
|
Ponikvar, R |
|
2001 |
33 |
7-8 |
p. 3365-3367 3 p. |
artikel |
329 |
Treatment of severe pneumonia in kidney transplant recipients
|
Benedetti, E. |
|
2001 |
33 |
7-8 |
p. 3652- 1 p. |
artikel |
330 |
Treatment with rabbit antithymocyte serum permits a cyclophosphamide-free approach to prevention of hdaf transgenic porcine kidney xenograft rejection in baboons
|
Ghanekar, A. |
|
2001 |
33 |
7-8 |
p. 3849-3850 2 p. |
artikel |
331 |
Tubular cells trans-differentiation induced by allogenic response can be modulated by cyclo-oxygenase-2 inhibitors
|
Peruzzi, L. |
|
2001 |
33 |
7-8 |
p. 3349-3350 2 p. |
artikel |
332 |
Twenty-year graft survival of living-related kidney transplantation in a single center
|
Ohmori, Y. |
|
2001 |
33 |
7-8 |
p. 3414-3415 2 p. |
artikel |
333 |
Update from studies in pediatric liver transplantation
|
McDiarmid, S.V. |
|
2001 |
33 |
7-8 |
p. 3604-3605 2 p. |
artikel |
334 |
Urolithiasis/calcinations in renal graft—a link with renal transplant bone disease treatment?
|
Ponikvar, J.B. |
|
2001 |
33 |
7-8 |
p. 3672-3673 2 p. |
artikel |
335 |
Usefulness of finger thermography to assess cyclosporine toxicity after heart transplantation
|
Doutreleau, S. |
|
2001 |
33 |
7-8 |
p. 3318-3319 2 p. |
artikel |
336 |
Usefulness of IgM anti-HCV in differential diagnosis between recurrent hepatitis C and acute rejection in liver transplant patients
|
Ciccorossi, P |
|
2001 |
33 |
7-8 |
p. 3641-3642 2 p. |
artikel |
337 |
Usefulness of two-point AUC0–4 monitoring in maintenance renal transplant patients
|
Uchida, K |
|
2001 |
33 |
7-8 |
p. 3128-3130 3 p. |
artikel |
338 |
Use of A2 kidneys for B and O kidney transplant recipients: report of a series of patients transplanted at a single center spanning a decade
|
Norman, D.J |
|
2001 |
33 |
7-8 |
p. 3327-3330 4 p. |
artikel |
339 |
Use of basiliximab in conjunction with either Neora/MMF/steroids or Prograf/MMF/steroids in simultaneous pancreas-kidney transplantation
|
Boggi, U |
|
2001 |
33 |
7-8 |
p. 3201-3202 2 p. |
artikel |
340 |
Use of isolated perfused rat liver model for testing liver preservation solutions
|
Ahmed, I |
|
2001 |
33 |
7-8 |
p. 3709-3711 3 p. |
artikel |
341 |
Use of laser doppler as a noninvasive measure of ischemia-reperfusion injury in the pig liver
|
Imber, C.J. |
|
2001 |
33 |
7-8 |
p. 3718-3719 2 p. |
artikel |
342 |
Vascular anomalies associated with biliary atresia in pretransplant survey
|
Chen, T.Y. |
|
2001 |
33 |
7-8 |
p. 3470-3471 2 p. |
artikel |
343 |
Within-patient controlled assessment of the influence of basiliximab on cyclosporine in pediatric de novo renal transplant recipients
|
Kovarik, J.M |
|
2001 |
33 |
7-8 |
p. 3172-3173 2 p. |
artikel |
344 |
Xenoreactivity of human natural antibodies with various porcine pancreatic cells
|
Zhang, W.J |
|
2001 |
33 |
7-8 |
p. 3865-3866 2 p. |
artikel |